Related Experiment Video

Updated: Aug 17, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Childhood idiopathic thrombocytopenic purpura

W W Zuelzer, J M Lusher

    American Journal of Diseases of Children (1960)
    |March 1, 1977
    PubMed

    Insights

    Idiopathic thrombocytopenia purpura (ITP) in children usually resolves on its own. Current evidence does not strongly support steroid use for shortening ITP duration or preventing serious bleeding like intracranial hemorrhage.

    Area of Science:

    • Pediatric Hematology
    • Immunology

    Background:

    • Idiopathic thrombocytopenia purpura (ITP) in children is typically a self-limiting condition.
    • Current management strategies for pediatric ITP are debated, particularly the use of corticosteroids.

    Purpose of the Study:

    • To evaluate the efficacy of corticosteroids in pediatric ITP.
    • To assess the evidence for steroids in reducing disease duration and intracranial hemorrhage risk.

    Main Methods:

    • Review of existing literature and clinical evidence regarding corticosteroid use in pediatric ITP.
    • Analysis of data on disease course and complication rates with and without steroid treatment.

    Main Results:

    • Little to no evidence supports that steroids shorten the natural course of pediatric ITP.
    • Conspicuous lack of evidence demonstrating that steroids reduce the risk of intracranial hemorrhage in pediatric ITP.

    Conclusions:

    • The authors no longer recommend routine steroid use for pediatric ITP.
    • If steroids are used, a selective approach based on bleeding severity is advised.

    More Related Videos

    A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry04:32

    A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

    Published on: June 5, 2019

    Purification of Platelets from Mouse Blood05:41

    Purification of Platelets from Mouse Blood

    Published on: May 7, 2019

    Related Concept Videos

    Structure and Function of Platelets01:18

    Structure and Function of Platelets

    The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
    Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Disorders of Hemostasis01:24

    Disorders of Hemostasis

    Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
    Thromboembolic Disorders
    Two factors primarily cause thromboembolic conditions.
    Immunodeficiency Diseases01:25

    Immunodeficiency Diseases

    Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
    There are three main causes of immunodeficiency disorders...
    Inflammatory Bowel Disease I: Ulcerative Colitis01:27

    Inflammatory Bowel Disease I: Ulcerative Colitis

    Introduction
    Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
    Risk Factors
    The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
    Type I Diabetes I: Introduction01:12

    Type I Diabetes I: Introduction

    Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...